528 related articles for article (PubMed ID: 7524798)
1. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
[TBL] [Abstract][Full Text] [Related]
2. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
Polk HC; Fink MP; Laverdiere M; Wilson SE; Garber GE; Barie PS; Hebert JC; Cheadle WG
Am Surg; 1993 Sep; 59(9):598-605. PubMed ID: 8396374
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
Shyr YM; Lui WY; Su CH; Wang LS; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Aug; 56(2):102-8. PubMed ID: 7553416
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
Vestweber KH; Grundel E
Eur J Surg Suppl; 1994; (573):57-60. PubMed ID: 7524797
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
Nord CE; Lahnborg G
Eur J Surg Suppl; 1994; (573):45-9. PubMed ID: 7524795
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Niinikoski J; Havia T; Alhava E; Pääkkönen M; Miettinen P; Kivilaakso E; Haapiainen R; Matikainen M; Laitinen S
Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin-tazobactam treatment for severe intra-abdominal infections.
Legrand JC; Bastin F; Belva P; Chastel C; Renaux J; Van Eukem P
Acta Chir Belg; 1995; 95(3):162-5. PubMed ID: 7610751
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
File TM; Tan JS
Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
Li C; Kuti JL; Nightingale CH; Mansfield DL; Dana A; Nicolau DP
J Antimicrob Chemother; 2005 Aug; 56(2):388-95. PubMed ID: 16002420
[TBL] [Abstract][Full Text] [Related]
13. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients.
Dougherty SH; Sirinek KR; Schauer PR; Fink MP; Fabian TC; Martin DH; Wiedermann B
Am Surg; 1995 Apr; 61(4):297-303. PubMed ID: 7893090
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
15. The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam.
Nord CE
Intensive Care Med; 1994 Jul; 20 Suppl 3():S35-8. PubMed ID: 7962987
[TBL] [Abstract][Full Text] [Related]
16. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
17. Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
Namias N; Solomkin JS; Jensen EH; Tomassini JE; Abramson MA
Surg Infect (Larchmt); 2007 Feb; 8(1):15-28. PubMed ID: 17381394
[TBL] [Abstract][Full Text] [Related]
18. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Eklund AE; Nord CE
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
[TBL] [Abstract][Full Text] [Related]
19. Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
Siami G; Christou N; Eiseman I; Tack KJ;
Antimicrob Agents Chemother; 2001 Feb; 45(2):525-31. PubMed ID: 11158750
[TBL] [Abstract][Full Text] [Related]
20. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
Lipsky BA; Giordano P; Choudhri S; Song J
J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
